Atom Investors LP I Teos Therapeutics, Inc. Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$16.57 - $35.1 $37,017 - $78,413	2,234 Added 24.92%	11,200 $231,000
Q1 2022 May 16, 2022	BUY	$31.92 - $47.45 $286,194 - $425,436	8,966 New	8,966 $289,000
Q2 2021 Aug 16, 2021	SELL	$17.9 - $36.1 $201,571 - $406,522	-11,261 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$30.86 - $44.2 $347,514 - $497,736	11,261 New	11,261 $385,000

166

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $257M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.